InflaMab: A novel inhibitor of inflammation targeting the NLRP3 Inflammasome

Research output: Contribution to conferenceAbstract

44 Downloads (Pure)
Original languageEnglish
Publication statusAccepted/In press - 30 Aug 2019

Cite this